Evidence map›Paper›PMID 42163168›Full record

ArticleBMC medical imaging2026

Development and validation of a multi-parametric MRI diagnostic model for differentiating hemangioma-like metastases from small (< 3 cm) hepatic hemangiomas: a size-based subgroup analysis.

Pengrui Gao, Funing Chu, Qingcheng Meng, Chongxiao Guan, Hongkai Zhang, Yong Zhang, Jinrong Qu

Abstract readValidation Study
In one paragraph

Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pengrui Gao *Department of Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, 127 Dongming Road, Zhengzhou, Henan, 450008, China.
Funing Chu *Department of Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, 127 Dongming Road, Zhengzhou, Henan, 450008, China.
Qingcheng MengDepartment of Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, 127 Dongming Road, Zhengzhou, Henan, 450008, China.
Chongxiao GuanDepartment of Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, 127 Dongming Road, Zhengzhou, Henan, 450008, China.
Hongkai ZhangDepartment of Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, 127 Dongming Road, Zhengzhou, Henan, 450008, China.
Yong ZhangDepartment of Biological Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, 450008, China.
Jinrong QuDepartment of Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, 127 Dongming Road, Zhengzhou, Henan, 450008, China. qjryq@126.com.

Funding

Henan Province Central Plains Talent Program (Nurturing Talent Series) 20240220Henan Provincial Medical Science and Technology Research Project LHGJ20210206Henan Provincial Scientific and Technological Project 232102310102
6 · The paper itself

Abstract

backgroundHemangioma-like metastases (HM) are rare but treacherous hypervascular malignancies that mimic the imaging features of benign hepatic hemangiomas (HH), particularly when lesions are small (< 3 cm). This resemblance creates a "diagnostic grey zone," often leading to misdiagnosis and inappropriate treatment delays. This study aims to develop and evaluate a multi-parametric MRI model to accurately distinguish small HM from HH and assess its diagnostic performance across different lesion size subgroups.

methodsThis retrospective study analyzed 149 lesions (81 HMs in 37 patients and 68 HHs in 48 patients), all smaller than 3 cm. Qualitative features on T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and dynamic contrast-enhanced (DCE) MRI were systematically evaluated. Multivariate logistic regression was employed to identify independent predictors and construct a combined diagnostic model. The calibration of the nomogram was assessed using calibration plots with 1,000 bootstrap resamples. Decision curve analysis (DCA) was performed to evaluate the clinical utility of the model by quantifying the net benefit at different threshold probabilities. The diagnostic performance was further validated in three size-based subgroups: 5-<10 mm, 10-<20 mm, and 20-<30 mm.

resultsFour MRI features emerged as robust independent predictors of HM: moderately hyperintense T2WI signal (OR, 18.97; 95% CI, 3.65-98.72), heterogeneous T2WI architecture (OR, 54.28; 95% CI, 6.50-453.56), ring-like arterial enhancement (OR, 90.76; 95% CI, 10.61-776.68), and unclear delayed phase boundary (OR, 11.05; 95% CI, 1.50-81.65). The combined multi-parametric model achieved superior diagnostic performance compared to any single feature, yielding an area under the curve (AUC) of 0.981, with a sensitivity of 95.1% and a specificity of 97.1%. Subgroup analysis revealed that while the diagnostic accuracy of individual features (especially DWI) improved with increasing lesion size, the combined model maintained high diagnostic stability even in the challenging 5-<10 mm subgroup.

conclusionThe proposed multi-parametric MRI model offers an effective, non-invasive tool for differentiating small HMs from HHs. The presence of heterogeneous T2WI signal and ring-like arterial enhancement should trigger high suspicion of malignancy, even in sub-centimeter lesions. This model has the potential to aid clinicians in risk stratification and may help reduce unnecessary biopsies.

Indexed as

HemangiomaLiver NeoplasmsMagnetic Resonance ImagingMultiparametric Magnetic Resonance ImagingAdultAgedContrast MediaDiagnosis, DifferentialDynamic Contrast Enhanced Magnetic Resonance ImagingFemaleHumansMaleMiddle AgedRetrospective StudiesSensitivity and SpecificityContrast MediaDiagnosisDifferentialHemangiomaHepatic metastasisLogistic modelsMagnetic resonance imaging

Identifiers

PMID42163168
PMCPMC13366846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.